The recall includes certain bottles of lisdexamfetamine dimesylate capsules, a generic version of the ADHD medication Vyvanse.

WASHINGTON — Several lots of a prescription ADHD medication have been recalled due to some failed lab tests, according to FDA Enforcement Reports. 

The nationwide recall covers several batches of the commonly used medication Lisdexamfetamine Dimesylate, a generic version of the ADHD medication Vyvanse. 

Sun Pharmaceutical Industries Inc. recalled the specified lots due to “Failed Dissolution Specifications,” meaning the sample pills failed to dissolve properly during testing. 

If this sounds familiar, that’s because it’s the same issue that led to a recall of more than 140,000 bottles of a popular cholesterol medication last month. 

The recall was issued on Oct. 28, and the FDA classified it as a Class II recall on Oct. 30, meaning use “may cause temporary health consequences, but the probability of a serious health issue is remote.” 

“These recalls are generally conducted at the retail level, and patients and consumers can continue using the medicine unless otherwise directed by the recalling company or FDA,” according to the classification description. 


ADHD Medication recall – Lisdexamfetamine dimesylate recall lot list

The following are the lot numbers and expiration dates for the recalled drugs, covering various strengths packaged in 100-count bottles. 

  • Lisdexamfetamine Dimesylate Capsules, 10 mg – 100-count bottle
    • AD42468 (Exp. Date 2/28/26) 
    • AD48705 (Exp. Date 4/30/26)
  • Lisdexamfetamine Dimesylate Capsules, 20 mg – 100-count bottle 
    • AD42469 (Exp. Date 2/28/26)
    • AD48707 (Exp. Date 4/30/26) 
  • Lisdexamfetamine Dimesylate Capsules, 30 mg – 100-count bottle 
    • AD42470 (Exp. Date 2/28/26)
    • AD48708 (Exp. Date 4/30/26) 
  • Lisdexamfetamine Dimesylate Capsules, 40 mg – 100-count bottle 
    • AD48709 (Exp. Date 4/30/26)
    • AD50894 (Exp. Date 5/31/26) 
  • Lisdexamfetamine Dimesylate Capsules, 50 mg – 100-count bottle 
    • AD48710 (Exp. Date 4/30/26)
    • AD50895 (Exp. Date 5/31/26) 
  • Lisdexamfetamine Dimesylate Capsules, 60 mg – 100-count bottle 
    • AD48711 (Exp. Date 4/30/26)
    • AD50896 (Exp. Date 5/31/26) 
  • Lisdexamfetamine Dimesylate Capsules, 70 mg – 100-count bottle 
    • AD48712 (Exp. Date 4/30/26)
    • AD50898(Exp. Date 5/31/26) 

No press release was issued for this recall, so there aren’t specific instructions for medication users. As Health.com notes, stopping ADHD medication abruptly is not recommended and could cause withdrawal symptoms. If you have any bottles affected by the recall, contact your pharmacy or doctor for guidance on next steps.